Medicare limits the patient cost of a one-month supply of each covered insulin product to $35 and does not apply a deductible to that insulin. The cap covers qualifying insulin under both Part D and Part B, but it does not make every diabetes-related supply free or guarantee that every insulin product is on a particular plan’s formulary. Coverage details still depend on the delivery method and plan.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. Our free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
Which insulin is subject to the $35 cap
Coverage depends on how insulin is delivered. Part D plans may cover injectable, inhaled, and certain pump insulin. Part B covers insulin used with a durable insulin pump that meets the Part B equipment rules. The same dollar ceiling applies to each covered product in those settings. Medicare’s insulin page applies the cap to each covered product. Medicare’s current insulin page says a one-month supply of each Part B- and Part D-covered insulin product costs no more than $35 and carries no deductible. A three-month supply therefore generally costs no more than $105 for each covered product.
The phrase “each covered insulin” prevents two common misunderstandings. A person using more than one insulin product can owe up to the cap for each product, and a plan is not required to cover every brand. Formulary status and the prescribed delivery method still matter.
How the monthly cap is applied
Under Part B, the cap applies when insulin is used with a covered durable insulin pump. Insulin self-administered by pen, needle, disposable patch pump, or inhaler generally belongs under Part D rather than the Part B durable-equipment benefit. The agency’s insulin cost guide distinguishes pump insulin from other delivery methods. Insulin-related supplies do not all share the insulin cap. Part D may cover syringes, needles, gauze, and alcohol swabs used for injections. Part B generally does not cover those supplies when the insulin is self-administered outside a covered durable pump.
The $35 ceiling applies even to a Part D enrollee receiving Extra Help, although that program may result in a lower charge. A Medigap policy that pays Part B coinsurance should cover the capped Part B insulin cost according to Medicare’s explanation.
Formulary limits can be challenged without changing the cap
Part D plans may apply prior authorization, step therapy, or quantity limits even though a covered monthly supply cannot cost more than $35. An exception request can also address a quantity limit that conflicts with the prescribed monthly dose. Medicare’s drug-plan rules allow the prescriber to request an exception when another formulary product would be less effective, cause adverse effects, or fail to meet the medical need. Approval determines whether the requested insulin becomes covered; the statutory cap then determines the patient cost for that covered supply.
Urgency changes the review clock. Medicare’s Part D appeal instructions permit an expedited request when delay may seriously jeopardize health or the ability to regain maximum function. The precise insulin name, strength, dosage form, rejection message, and prescriber statement should accompany the request. Buying a nonformulary product for cash before a decision can create a reimbursement dispute that the $35 cap alone does not resolve.
The difference between Part B and Part D insulin
The protection applies to people with Medicare whose prescribed insulin product is covered under Part D or under Part B through a qualifying pump. People without drug coverage, using a nonformulary product without an approved exception, or buying supplies outside Medicare’s coverage rules may face different charges.
Checking the plan and pharmacy before pickup
Before filling a prescription, the enrollee or representative can check the plan formulary for the exact insulin name, concentration, and delivery form. A pharmacy can confirm the covered product and expected monthly charge before processing a longer supply. If a prescribed insulin is not on the formulary, the prescriber can discuss a covered alternative or request a formulary exception based on medical need. Changing products should be a clinical decision; the cost rule does not replace guidance from the treating professional.
Receipts and plan explanations should be reviewed for a deductible or charge above $35 per monthly supply of each covered product. A pricing error can be raised with the plan and, if unresolved, through the coverage-determination or appeal process. The cap is strong but product-specific. It covers insulin itself, not every supply or device, and it applies only when Medicare covers the product. The literal verified result is no more than $35 for each one-month supply of Part B- or Part D-covered insulin, with no insulin deductible.
The cap is measured by a month’s supply, not simply by each pharmacy visit. A partial fill, emergency supply, or change in dosage can require the plan and pharmacy to calculate the applicable amount carefully. For a standard three-month supply of one covered product, Medicare states the patient generally pays no more than $105. A second insulin product can carry its own capped amount because the protection applies separately to each covered product.
Plan changes can still affect access even when the dollar ceiling remains. Formularies can use preferred products, prior authorization, or quantity limits. During annual enrollment, an insulin user should enter the exact product and pharmacy into the plan comparison rather than comparing premiums alone. A plan with a low premium may be inconvenient if the required insulin is nonformulary or the preferred pharmacy is inaccessible.
For pump users, the equipment pathway should be reviewed as a package. The durable pump, insulin used in it, infusion supplies, and supplier participation can follow connected but distinct Part B rules. A supplier should explain which items are included in the Medicare assignment and which are separately billed. That prevents the $35 insulin cap from being mistaken for a cap on the entire pump system.
This article was researched and drafted with AI assistance and reviewed against the linked primary sources.
More Financial Reading
- The ideal retirement withdrawal rate so your savings actually last
- Bank statements: how long to keep them and when to toss them
David M. Keller is a finance writer based in Columbus, Ohio, covering personal finance and consumer-focused economic topics. He earned his degree in journalism from Ohio University and began his career reporting on local business and economic trends for a regional media outlet. Since then, he has contributed to a variety of online publications, focusing on clear, practical coverage of topics such as cost of living, debt, and everyday financial decision-making.
